A Trial of Intravenous Fluids During Labor

NCT ID: NCT01110005

Last Updated: 2024-01-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

318 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-04-30

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if intrapartum use of a glucose-containing solution will improve the outcomes in pregnant women and their babies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a multi-center, prospective, single-blind randomized trial of two types of IV fluids for maintenance hydration during labor. This study will be conducted at 4 sites: Reading (Reading Hospital), Allentown (Lehigh Valley), St. Luke Hospital and Hershey (Penn State College of Medicine). It will include 1524 pregnant women at ≥ 36 weeks presenting in spontaneous labor for anticipated delivery.

The primary research hypothesis is that intravenous hydration during labor with a glucose-containing fluid will lead to more efficient uterine contractility and will lead to a reduction of cesarean delivery. The primary outcome measure is the occurrence of a cesarean birth during the study period. The primary analysis will use an intent-to-treat approach to examine differences between the two IV fluid treatments in the proportion of deliveries requiring cesarean section.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ketosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

D5 Lactated Ringer's solution (D5LR)

IV fluid containing glucose administered throughout labor at an average infusion rate of 125 ml/hr.

Group Type ACTIVE_COMPARATOR

D5 Lactated Ringer's Solution (D5LR)

Intervention Type OTHER

D5LR IV fluid

Lactated Ringer's solution (LR)

Non-glucose IV fluid administered throughout labor at an average infusion rate of 125 ml/hr.

Group Type ACTIVE_COMPARATOR

Lactated Ringer's Solution (LR)

Intervention Type OTHER

LR IV fluid

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

D5 Lactated Ringer's Solution (D5LR)

D5LR IV fluid

Intervention Type OTHER

Lactated Ringer's Solution (LR)

LR IV fluid

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women of any age with a singleton gestation in spontaneous labor at greater than or equal to 36 weeks without contraindication to participation.
2. These women will be in good health and candidates for vaginal delivery.

Exclusion Criteria

1. Patients who are not candidates for vaginal delivery. This may be due to fetal malpresentation, prior cesarean section, multiple gestations, etc.
2. Patients presenting for induction of labor or requiring induction upon admission.
3. Patients presenting for scheduled cesarean section.
4. Patients with any form of diabetes or glucose dysregulation condition.
5. Concurrent use of steroids.
6. Patients presenting in active labor with advanced cervical dilation (≥ 6 cm).
7. Subjects participating in another labor and delivery related clinical trial that conflicts with this trial (as determined by the site PI).
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lehigh Valley Hospital

OTHER

Sponsor Role collaborator

The Reading Hospital and Medical Center

OTHER

Sponsor Role collaborator

St. Luke's Hospital, Pennsylvania

OTHER

Sponsor Role collaborator

Milton S. Hershey Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Richard S. Legro, M.D.

Professor, Obstetrics and Gynecology and Public Health Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard S Legro, M.D.

Role: STUDY_DIRECTOR

The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, United States

John Smulian, M.D.

Role: PRINCIPAL_INVESTIGATOR

Lehigh Valley Hospital, Allentown, Pennsylvania, United States

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lehigh Valley Hospital

Allentown, Pennsylvania, United States

Site Status

St. Luke Hospital

Bethlehem, Pennsylvania, United States

Site Status

The Penn State University

Hershey, Pennsylvania, United States

Site Status

The Reading Hospital and Medical Center

Reading, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Dapuzzo-Argiriou LM, Smulian JC, Rochon ML, Galdi L, Kissling JM, Schnatz PF, Gonzalez Rios A, Airoldi J, Carrillo MA, Maines J, Kunselman AR, Repke J, Legro RS. A multi-center randomized trial of two different intravenous fluids during labor. J Matern Fetal Neonatal Med. 2016;29(2):191-6. doi: 10.3109/14767058.2014.998190. Epub 2015 Sep 4.

Reference Type DERIVED
PMID: 25758624 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

32118

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intrapartum Hydration
NCT01242293 COMPLETED NA
Anticholinergics for Cervical Edema in Labor
NCT06702670 NOT_YET_RECRUITING PHASE2/PHASE3
Amniotic Fluid Analysis
NCT06131684 NOT_YET_RECRUITING EARLY_PHASE1